Back
Viad Vs. NovoCure Industry Stock Comparison
Buy
77
VVI
Viad
Last Price:
44.97
Seasonality Move:
7.29%
Buy
82
NVCR
NovoCure
Last Price:
30.52
Seasonality Move:
2.04%
Buy
77
Viad (VVI)
is a Buy
Is Viad a Buy, Sell or Hold?
- The current Viad [VVI] share price is $44.95. The Score for VVI is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
- VVI is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
82
NovoCure (NVCR)
is a Buy
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $29.85. The Score for NVCR is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
- NVCR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
NVCR Stock Price Chart
VVI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.47 | Buy |
Relative Strength Index (14 RSI): | 62.5 | Buy |
Chaikin Money Flow: | 75206 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (39.63 - 44.95) | Buy |
Bollinger Bands (100): | (32.58 - 40.84) | Buy |
NVCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.5 | Buy |
Relative Strength Index (14 RSI): | 83.96 | Buy |
Chaikin Money Flow: | 5788123 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.1 - 20.5) | Buy |
Bollinger Bands (100): | (15.67 - 19.79) | Buy |
VVI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 43.89 | Buy |
20-day SMA: | 43.35 | Buy |
50-day SMA: | 39.47 | Buy |
200-day SMA: | 35.95 | Buy |
8-day EMA: | 44.18 | Buy |
20-day EMA: | 42.98 | Buy |
50-day EMA: | 40.27 | Buy |
200-day EMA: | 36 | Buy |
NVCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 19.74 | Buy |
20-day SMA: | 18.16 | Buy |
50-day SMA: | 16.86 | Buy |
200-day SMA: | 17.27 | Buy |
8-day EMA: | 20.98 | Buy |
20-day EMA: | 18.81 | Buy |
50-day EMA: | 17.73 | Buy |
200-day EMA: | 18.95 | Buy |
Viad Earnings Growth & VVI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.43 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $0.88 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.32 per share.
Viad Technical Analysis
Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovoCure Technical Analysis
Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |